Did empowerment clubs increase PrEP continuation among adolescent girls and young women in South Africa and Tanzania? Results from the EMPOWER randomised trial

30 October 2018
Sephy Valuks

Join us for a free webinar on Tuesday 27 November, 12 noon GMT.

PrEP is a new HIV prevention technology that is likely to benefit adolescent girls and young women (AGYW) in Eastern and Southern Africa at substantial risk for HIV infection. Strategies to support PrEP uptake and address barriers to consistent use are urgently needed. As part of the EMPOWER study, a randomised controlled trial was conducted to evaluate whether empowerment clubs increase PrEP uptake and continuation among AGYW in South Africa and Tanzania.

This Learning Lab will present findings from the trial presented at IAS and share lessons learned from our experience of delivering combination HIV prevention to adolescent girls and young women.

Sinead Delany-Moretlwe is Associate Professor and Director of Research at Wits RHI. A South African-born medical doctor, her experience is primarily in sexual and reproductive health and HIV prevention research. Currently she is a principal investigator on a large phase III trial of injectable cabotegravir as PrEP, and three demonstration projects of PrEP for adolescent girls and young women, with a particular focus on evaluating interventions that may address the social and structural barriers to PrEP use in young women.


07:00 Washington

12:00 London

14:00 Johannesburg

15:00 Nairobi

17:30 New Delhi


To join the webinar, you must call in AND join online to hear audio and view the slides. 

1. Register online now. You will then receive an email giving you the access code and toll-free numbers to dial.

2. Log in to Ready Talk as a participant online, shortly before the presentation begins, so you can see the slides. Use access code 9272774. 

3. Dial in to Ready Talk on your telephone, shortly before the presentation begins, so you can hear the presenter speaking. Use access code 9272774. 

If your country does not have a toll-free number, you can dial in for free through Skype using the US number 866-740-1260. 

Please send enquiries to Sephy [dot] Valuks [at] LSHTM [dot] ac [dot] uk by Friday 23 November 2018.